ENTEROBSEENTERO HEALTHCARE SOLU LLowNeutral
Announced Thu, 22 Oct, 2026 · 18:50 IST

Board to review September quarter results on November 4

ENTERO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.5%Reaction day
₹1492.00
prior close
₹1471.00
announcement price
After-mkt
timing
Nifty Microcap 250market-2.3%+0.8% vs market
Retailing peers, median of 59sector · industry level-1.7%+0.3% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 0.3 pts more than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.7
10m
-0.2
15m
-0.7
30m
-0.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.5-2.3+0.8-1.7+0.3
Next day
-1.4-1.9+0.5-1.1-0.3
2d
+5.9pendingpending+0.7+5.2
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Retailing peers, median of 59Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on November 4, 2026, to approve the unaudited company-only and combined financial results for the quarter ended September 30, 2026, along with a review report. Trading in the company’s securities has been closed since October 1 and will remain closed until 48 hours after the results are declared.

Likely market impact

No results figures were provided. The announcement mainly confirms a near-term results date, and the stock may react when the September quarter numbers are released.